Atrium Medical Corp. C-Qur Mesh

The Atrium C-Qur hernia mesh docket, with 127 actions coordinated in the District of New Hampshire roughly a decade after centralization, sits at a moderate, mature stage of its lifecycle. Claims allege that the mesh's fish-oil-derived coating, intended to reduce adhesion to internal organs, instead provokes an inflammatory reaction that can cause chronic pain, infection, and mesh adherence requiring revision surgery.

That coating-specific defect theory distinguishes this docket from other hernia mesh litigation proceeding against different manufacturers and products, which matters for underwriting: a funder evaluating a C-Qur claim should confirm the specific product used, since mesh litigation spans multiple manufacturers and coating technologies with distinct causation records and litigation postures. With a decade of prior bellwether and case-specific development behind it, claims in this docket generally come with an established evidentiary framework, meaning implant records, revision-surgery documentation, and imaging or pathology findings tied to the coating reaction, that supports more confident underwriting than an earlier-stage docket would.

Medical-lien exposure is a standard consideration given the cost of mesh-revision surgery and related infection treatment. For a firm holding a modest C-Qur inventory, the docket's moderate scale supports either single-matter or small-portfolio financing depending on how many claims a given firm holds, rather than dictating one structure over the other. Because settlement-program timing in the broader hernia mesh litigation space has varied considerably by manufacturer, funding structures here should be built around this docket's own record rather than assumptions imported from a differently postured mesh MDL.

Criterica Capital's mass tort finance product applies to claims in this docket. A structural view of the docket's current bellwether and settlement posture, useful given how much mesh litigation varies by manufacturer and product line, is available through Criterica Intelligence.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.